The Director of the Charles Bonnet Syndrome Foundation, Scot Muirden, recently hosted a two-part Live Q&A series for Glaucoma Australia, where he answered some of the most commonly asked questions about Charles Bonnet Syndrome.
Glaucoma Australia and its Patron, the Governor-General of Australia, His Excellency the Honourable David Hurley, are pleased to announce the 2023 recipient of the ‘Quinlivan’ Research Grants Program.
We are inviting individuals who have accessed eyecare services previously to participate in a focus group discussion so that we can better understand what good eye care means to the patient.
Glaucoma Australia’s successful patient support program now has a new name – SiGHTWiSE. The new brand identity, which is warm and inviting, signals a brighter future for people diagnosed with glaucoma and their families.
Researchers at UNSW are conducting a clinical research study to investigate the link between glaucoma and the levels of vitamins and/or inflammatory mediators in tears. You could help this important research by joining this study!
This year’s Include a Charity Initiative ran from the 4 – 10 September, encouraging Australians to leave a charitable gift in their Wills to create a lasting and positive impact on future generations.
I was hit in the left eye with a fully extended octopus strap and destroyed the Schlemm canal of my eye. Dr Ivan Goldberg took over and performed a Trabeculectomy followed by injections of 5-fluorouracil into the eyeball to prevent growth of scar cells over the Trabeculectomy.
I didn't have any tell-tale signs of vision loss but thankfully my Optometrist detected increased pressure during a routine eye check. I am grateful it was picked up early and knew I had to act quickly.
Researchers have developed a gene therapy that has lowered intraocular pressure (IOP) in animal models, suggesting that glaucoma can be readily treated with gene therapy–based methods, paving the way for deployment in clinical trials.